about
α-L-fucosidase inhibition by pyrrolidine-ferrocene hybrids: rationalization of ligand-binding properties by structural studiesCiprofloxacin Derivatives Affect Parasite Cell Division and Increase the Survival of Mice Infected with Toxoplasma gondiiEnhancement of the antimalarial activity of ciprofloxacin using a double prodrug/bioorganometallic approach.Plasmodium falciparum apicoplast drugs: targets or off-targets?A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus.New heterocyclic compounds: Synthesis and antitrypanosomal properties.Iminosugar-ferrocene conjugates as potential anticancer agents.Deciphering the Resistance-Counteracting Functions of Ferroquine in Plasmodium falciparum-Infected Erythrocytes.The ferroquine antimalarial conundrum: redox activation and reinvasion inhibition.Opening up the advantages of the ruthenocenic bioprobes of ferroquine: distribution and localization in Plasmodium falciparum-infected erythrocytes.The antimalarial ferroquine: role of the metal and intramolecular hydrogen bond in activity and resistance.Ferroquine, an ingenious antimalarial drug: thoughts on the mechanism of action.Statistical methodology for the detection of small changes in distances by EXAFS: application to the antimalarial ruthenoquine.MmpL8 controls virulence and production of a previously unknown glycolipid familyIn situ nanochemical imaging of label-free drugs: a case study of antimalarials in Plasmodium falciparum-infected erythrocytesA piperidinol-containing molecule is active against Mycobacterium tuberculosis by inhibiting the mycolic acid flippase activity of MmpL3Structure-Based Design and Synthesis of Piperidinol-Containing Molecules as New Mycobacterium abscessus Inhibitors
P50
Q27684758-410921F3-520A-4B66-9161-5A5CF8938C9DQ28547065-AD03E11E-1350-430B-AB24-A619AECAF247Q33515839-3BD48526-79E0-44FA-B1CC-AD05C6CED261Q34227325-6CF2D4A4-2726-4121-8456-EDA39D1819B3Q36001167-A4974A37-C168-4005-8C4F-0834B0D87783Q38891663-5C4AF49E-A262-4852-A066-F1D854A20C2AQ39327878-24FAB0DF-9EAC-4339-85A0-B8175A772F0EQ39734520-794F0A6B-C4CA-4142-9D97-A5F8356C9ECEQ41925428-E8E45893-6313-492F-A875-FA8D4703DBA4Q41929217-BD75C987-4C4E-4E2B-A8C4-A25FFD1A6B42Q41934155-25FA1AF1-0CAD-43A1-BE96-F5F96934D2FBQ46237143-E07C13D4-334F-4EAD-8D93-A11B6EE2B305Q47744445-C7C741CA-F47E-4C84-B2DB-0E6CCAD619B2Q57292167-E0446FAA-6971-485B-B7DF-56CF5A4DD661Q63362570-07C00734-9A14-4E5A-8289-9121F969CCCFQ90339325-DDE5B1DA-81BC-4EA3-9407-3B02D058BDC7Q90642298-D67A1D0C-356D-4C8A-B47A-7D5FB1AF8C0A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Faustine Dubar
@ast
Faustine Dubar
@en
Faustine Dubar
@es
Faustine Dubar
@nl
type
label
Faustine Dubar
@ast
Faustine Dubar
@en
Faustine Dubar
@es
Faustine Dubar
@nl
prefLabel
Faustine Dubar
@ast
Faustine Dubar
@en
Faustine Dubar
@es
Faustine Dubar
@nl
P106
P1153
35387866700
P31
P496
0000-0002-0233-7067